Anika Therapeutics Inc. (ANIK) financial statements (2020 and earlier)

Company profile

Business Address 32 WIGGINS AVENUE
BEDFORD, MA 01730
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18515915712513810763
Cash and cash equivalents1578913310411110063
Short-term investments27702421287 
Receivables23212428221719
Inventory, net of allowances, customer advances and progress billings22212216151211
Inventory22212216151211
Prepaid expense     0 
Other undisclosed current assets4232122
Total current assets:23420320617017613995
Noncurrent Assets
Operating lease, right-of-use asset23
Property, plant and equipment51545652403233
Intangible assets, net (including goodwill)15171917192328
Goodwill8887789
Intangible assets, net (excluding goodwill)891110121519
Other noncurrent assets751    
Other undisclosed noncurrent assets   0000
Total noncurrent assets:96767670595561
TOTAL ASSETS:331279283240236194156
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14101391799
Accounts payable4372813
Accrued liabilities4266556
Employee-related liabilities64   3 
Taxes payable 0  4 1
Restructuring reserve     0
Deferred revenue and credits   00
Other undisclosed current liabilities21   (3) 
Total current liabilities:16111391769
Noncurrent Liabilities
Long-term debt and lease obligation21      
Operating lease, liability21
Liabilities, other than long-term debt546981011
Deferred revenue and credits 0002
Deferred tax liabilities, net457798
Deferred income tax liabilities4
Other liabilities0112111
Total noncurrent liabilities:2646981011
Total liabilities:42151917251620
Stockholders' equity
Stockholders' equity attributable to parent288264263223211178136
Common stock0000000
Additional paid in capital49516962827871
Accumulated other comprehensive loss(6)(6)(5)(7)(7)(4)(2)
Retained earnings24521820016813610567
Total stockholders' equity:288264263223211178136
TOTAL LIABILITIES AND EQUITY:331279283240236194156

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues1151061131039310675
Revenue, net1131039310675
Cost of revenue
(Cost of Goods and Services Sold)
(29)(31)(27)(24)(21)(21)(23)
Gross profit:86748679728452
Operating expenses(52)(53)(40)(29)(24)(28)(25)
Other undisclosed operating income     55
Operating income:34224651486133
Nonoperating income (expense)
(Foreign Currency Transaction Gain (Loss), before Tax)
     (1)0
Income from continuing operations before equity method investments, income taxes:34224651486133
Other undisclosed income (loss) from continuing operations before income taxes210001(0)
Income from continuing operations before income taxes:36234651486232
Income tax expense(9)(4)(14)(18)(17)(23)(12)
Net income available to common stockholders, diluted:27193233313821

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:27193233313821
Other comprehensive income (loss)(0)(1)3(1)(2)(3)1
Comprehensive income, net of tax, attributable to parent:27183432293622

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: